首页|钙周期素结合蛋白与乳腺癌临床的相关性研究

钙周期素结合蛋白与乳腺癌临床的相关性研究

扫码查看
目的:研究钙周期素结合蛋白(CacyBP/SIP)在乳腺癌的表达与其临床病理特征、复发转移及预后间的关系.方法:应用逆转录-聚合酶链反应(RT-PCR)及免疫组化法(IHC)在mRNA及蛋白表达水平验证CacyBP/SIP在乳腺癌组织、癌旁正常乳腺组织中的表达情况,探讨其表达结果与患者临床病理特征、ER,PR,C-erbB-2的表达、复发转移及预后是否有相关性.结果:①CacyBP/SIP在乳腺癌组织中高表达(56.96%),主要表达于胞质,癌旁正常组织中无表达或低表达(35.44%).②CacyBP/SIP在乳腺癌组织的表达与淋巴结转移、肿瘤分期、组织学分级相关:有淋巴结转移、肿瘤分期越晚、组织学分级越高,则CacyBP/SIP的阳性表达率越高;与患者年龄、月经状态、肿瘤大小、ER,PR,C-erbB-2表达无关.③CacyBP/SIP在乳腺癌组织的表达与乳腺癌复发转移相关:复发转移组CacyBP/SIP阳性表达率较无复发转移组高.④CacyBP/SIP在乳腺癌组织的表达与患者生存率呈负相关,与累积复发转移风险呈正相关.结论:CacyBP/SIP可能参与了乳腺癌的发生发展、侵袭转移,有可能成为乳腺癌预后不良的生物学指标之一.
Correlation between CacyBP/SIP and breast carcinoma
AIM:To study the relationship between the expression of CacyBP/SIP in breast carcinoma and its pathologic characteristics,relapse,metastasis and prognosis.METHODS:The expression of CacyBP/SIP in breast carcinoma was detected by immunohistochemistry(IHC)and reverse transcription-polymerase chain reaction(RT-PCR).RESULTS:The expression rate of CacyBP/SIP was 56.96%(45/79)in breast carcinoma tissue samples and 35.44%(28/79)in adjacent noncancerous breast tissues,respectively.CacyBP/SIP was mainly located in the cytoplasm of breast carcinoma.The expression of CacyBP/SIP in breast cancer was positively related with clinical pathologic characteristics,including metastasis of lymph node,tumor staging,and histology grading.There was no relationship between CacyBP/SIP expression in breast carcinoma and patient's age,status of menses,tumor size and expression of ER,PR and CerbB-2,respectively.The expression of CacyBP/SIP in breast carcinoma was also related to relapse and metastasis.The CacyBP/SIP expression was higher in metastatic group compared to that in no metastatic group.The expression of CacyBP/SIP in breast carcinoma had a negative correlation with patients'survival,and it had a positive correlation with accumulated risk of relapse and metastasis.CONCLUSION:The result demonstrated that there existed higher expression of CacyBP/SIP in breast carcinoma.CacyBP/SIP was involved in the occurrence,development,and metastasis of breast carcinoma.It may be one of factors to evaluate the poor prognosis in patients with breast carcinoma.

CacyBP/SIPbreast carcinomarelapsemetastasisprognosis

王宁菊、马刚、翟慧虹

展开 >

宁夏医科大学附属医院肿瘤内科,宁夏,银川,750004

宁夏医科大学附属医院消化内科,宁夏,银川,750004

CacyBP/SIP 乳腺肿瘤 复发 转移 预后

宁夏高等学校科学研究项目

宁高教2008293号

2009

第四军医大学学报
第四军医大学

第四军医大学学报

CSTPCDCSCD北大核心
影响因子:0.599
ISSN:1000-2790
年,卷(期):2009.30(21)
  • 6
  • 2